Treating PIK3CA and EGFR overexpressing breast cancers with lithium citrate

被引：1
|
作者：
Brand, Toni M. [1 ]
Wheeler, Deric L. [1 ]
机构：
[1] Univ Wisconsin, Dept Human Oncol, Sch Med & Publ Hlth, Ctr Comprehens Canc, Madison, WI 53201 USA
来源：
CANCER BIOLOGY & THERAPY | 2011年 / 11卷 / 03期
关键词：
breast cancer; epidermal growth factor receptor (EGFR); lithium citrate; PIK3CA; receptor tyrosine kinase (RTK); METASTATIC COLORECTAL-CANCER; LUNG-CANCER; CETUXIMAB; MUTATIONS; KRAS; THERAPY;
D O I：
10.4161/cbt.11.3.14696
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：368 / 370
页数：3
相关论文
共 50 条
  • [1] PIK3CA: a Target or a Marker in Breast Cancers
    Dieci M.V.
    Guarneri V.
    Current Breast Cancer Reports, 2015, 7 (3) : 161 - 169
  • [2] PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells
    Higgins, Michaela J.
    Beaver, Julia A.
    Wong, Hong Yuen
    Gustin, John P.
    Lauring, Josh D.
    Garay, Joseph P.
    Konishi, Hiroyuki
    Mohseni, Morassa
    Wang, Grace M.
    Cidado, Justin
    Jelovac, Danijela
    Cosgrove, David P.
    Tamaki, Akina
    Abukhdeir, Abde M.
    Park, Ben Ho
    CANCER BIOLOGY & THERAPY, 2011, 11 (03) : 358 - 367
  • [3] Oncogenic Mutations of PIK3CA in Human Cancers
    Samuels, Yardena
    Waldman, Todd
    PHOSPHOINOSITIDE 3-KINASE IN HEALTH AND DISEASE, VOL 2, 2011, 347 : 21 - 41
  • [4] EGFR, PIK3CA, KRAS and BRAF mutations in meningiomas
    Bujko, Mateusz
    Kober, Paulina
    Tysarowski, Andrzej
    Matyja, Ewa
    Mandat, Tomasz
    Bonicki, Wieslaw
    Siedlecki, Janusz Aleksander
    ONCOLOGY LETTERS, 2014, 7 (06) : 2019 - 2022
  • [5] KRAS, EGFR AND PIK3CA mutation in triple negative breast carcinomas
    Erdogan, G.
    Ozcan, M.
    Karaveli, F. S.
    Pestereli, H. E.
    INTERNATIONAL JOURNAL OF MEDICAL RESEARCH & HEALTH SCIENCES, 2016, 5 (03): : 95 - 104
  • [6] The PIK3CA gene is mutated with high frequency in human breast cancers
    Bachman, KE
    Argani, P
    Samuels, Y
    Silliman, N
    Ptak, J
    Szabo, S
    Konishi, H
    Karakas, B
    Blair, BG
    Lin, C
    Peters, BA
    Velculescu, VE
    Park, BH
    CANCER BIOLOGY & THERAPY, 2004, 3 (08) : 772 - 775
  • [7] A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancers
    Jelovac, Danijela
    Beaver, Julia A.
    Balukrishna, Sasidharan
    Wong, Hong Yuen
    Toro, Patricia Valda
    Cimino-Mathews, Ashley
    Argani, Pedram
    Stearns, Vered
    Jacobs, Lisa
    VanDenBerg, Dustin
    Kessler, Jill
    Jeter, Stacie
    Park, Ben H.
    Wolff, Antonio C.
    HUMAN PATHOLOGY, 2014, 45 (04) : 880 - 883
  • [8] Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases
    Palimaru, Irina
    Brugmann, Anja
    Wium-Andersen, Marie Kim
    Nexo, Ebba
    Sorensen, Boe Sandahl
    SPRINGERPLUS, 2013, 2 : 1 - 7
  • [9] Analysis of PIK3CA Mutations in Breast Cancer Subtypes
    Arsenic, Ruza
    Lehmann, Annika
    Budczies, Jan
    Koch, Ines
    Prinzler, Judith
    Kleine-Tebbe, Anke
    Schewe, Christiane
    Loibl, Sibylle
    Dietel, Manfred
    Denkert, Carsten
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2014, 22 (01) : 50 - 56
  • [10] PIK3CA alterations in Middle Eastern ovarian cancers
    Abubaker, Jehad
    Bavi, Prashant
    Al-Haqawi, Wael
    Jehan, Zeenath
    Munkarah, Adnan
    Uddin, Shahab
    Al-Kuraya, Khawla S.
    MOLECULAR CANCER, 2009, 8
12345